We also observed that proteins involved in fatty acid oxidation, such as AMACR, ACOX-3 and DBP, were restricted to the tumour cells, which is consistent with the presence of a metabolic pathway different from glycolysis, and compatible with oxidative phosphorylation in prostate cancer cells. The gene discussed is AMACR; the disease is prostate cancer.